Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation
NCT ID: NCT02501577
Last Updated: 2015-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2015-03-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Learning Curve of Fiberoptic Intubation Through Supraglottic Airway Device
NCT04482166
Fibre-optic Guided Tracheal Intubation Through SADs
NCT03118596
Supraglottic Airway Devices in Pediatric Difficult Airway Situations
NCT02572232
Comparative Evaluation of Periglottic Airway Devices With Performed Shape
NCT05639439
Low Skill Fibreoptic Intubation I-gel vs Air-Q
NCT02663843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SAD 1
FOI for placement
SAD 1
Placement and fiberoptic control
SAD 2
FOI für placement
SAD 2
Placement and fiberoptic control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SAD 1
Placement and fiberoptic control
SAD 2
Placement and fiberoptic control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Regensburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Metterlein
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Metterlein, MD
Role: STUDY_CHAIR
Uni Regensburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Regensburg
Regensburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sadfoi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.